Recent advances are furthering our understanding of the role of iron in disease. CLI caught up with Professor Martina U. Muckenthaler and Dr Oriana Marques to learn more about the importance of iron homeostasis.
The EURORealTime SARS-CoV-2/Influenza A/B is a multiplex PCR-based test for fast and efficient detection and differentiation of SARS-CoV-2 and influenza viruses A and B from throat swabs. The assay aids discrimination between the clinically similar diseases COVID-19 and influenza, identification of potential co-infections and epidemiological surveillance. The EURORealTime SARS-CoV-2/Influenza A/B incorporates reverse transcription and real-time […]
Ziath, working with the Hubrecht Institute (Utrecht, Netherlands), has developed a pioneering automated test robot, called STRIP-1, which can process up to 20,000 samples for SARS-CoV-2 testing in just 24 hours. This makes it much faster than all other automated SARS-CoV-2 testing systems used to date. In addition, all samples can be tracked precisely because […]
A study out of the Michael G. DeGroote Institute for Infectious Disease Research at McMaster University has resulted in the discovery of a promising new antimalarial compound.
BBMRI, EATRIS and ECRIN, the medical European research infrastructures, supported by the European Strategy Forum on Research Infrastructures (ESFRI), have joined forces by forming the European Alliance of Medical Research Infrastructures (EU-AMRI). EU-AMRI aims to facilitate the effective and efficient use of scientific services, expertise and tools by academia and industry for the seamless translation […]
Professor Braeckmans from Ghent University focused the last ten years on a method for safe engineering of therapeutic cells with photothermal nanofibers. The study published in Nature Nanotechnology gives insight in how these biocompatible photothermal nanofibers were developed, and how, upon laser irradiation, cells that come in contact with those nanofibers become permeabilized and can […]
Inhibitors that block the activity of the proteasome are already applied to treat various types of cancer. However, existing drugs affect proteasomes in all the cells of our body, which can lead to unwanted side-effects in healthy cells.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
